During mammalian cerebral cortex development, the G1-phase of the cell cycle is known to lengthen, but it has been unclear which neural stem and progenitor cells are affected. In this paper, we develop a novel approach to determine cell-cycle parameters in specific classes of neural stem and progenitor cells, identified by molecular markers rather than location. We found that G1 lengthening was associated with the transition from stem cell-like apical progenitors to fate-restricted basal (intermediate) progenitors. Unexpectedly, expanding apical and basal progenitors exhibit a substantially longer S-phase than apical and basal progenitors committed to neuron production. Comparative genome-wide gene expression analysis of expanding versus committed progenitor cells revealed changes in key factors of cell-cycle regulation, DNA replication and repair and chromatin remodelling. Our findings suggest that expanding neural stem and progenitor cells invest more time during S-phase into quality control of replicated DNA than those committed to neuron production.
Neural stem and progenitor cells shorten S-phase on commitment to neuron production Yoko Arai uring development of the mammalian cerebral cortex, neurons are generated from two principal classes of neural progenitor cells (NPCs). One class consists of somatic stem celllike neuroepithelial cells and radial glial cells, collectively referred to as apical progenitors (APs), which exhibit apical-basal polarity, undergo mitosis at the ventricular (apical) surface, and the cell bodies of which constitute the ventricular zone (VZ) [1] [2] [3] [4] . The second class consists of NPCs that originate from apical mitoses, translocate their cell bodies through the VZ in the basal direction, delaminate from the ventricular surface to form the subventricular zone (SVZ), downregulate apical-basal polarity (at least in rodents) and undergo mitosis in the basal VZ or SVZ [5] [6] [7] [8] [9] ; these NPCs are called basal progenitors (BPs) 2 or intermediate progenitor cells 4 . Regarding the balance between NPCs and neurons, there are three principal types of AP and BP divisions: self-expanding symmetric proliferative, self-renewing asymmetric BP-or neuron-generating, and selfconsuming neurogenic 3, 10 . The spatial organization of APs and BPs in M-phase is one key determinant of the type of NPC division 2, 3, 11 . Another key determinant is of a temporal nature. Specifically, concomitant with progression of neurogenesis, cell-cycle length of cortical NPCs in the VZ is known to increase [12] [13] [14] , and there are intriguing links between NPC cell-cycle length and neuron output [15] [16] [17] . NPC cell-cycle lengthening pertains specifically to the G1-phase 12, 14, 15 and can be a cause (rather than a consequence) of neurogenesis [16] [17] [18] . Conversely, reducing cell-cycle length, specifically G1, of NPCs in the cerebral cortex has recently been found to promote their expansion, with a transient delay in neurogenesis 19, 20 . However, taking into account the coexistence of APs and newborn BPs in the VZ with the onset of neurogenesis, it is unclear whether cell-cycle lengthening of NPCs in the VZ, concomitant with the progression of neurogenesis, reflects the following: cell-cycle lengthening in an AP sub-population, as previously assumed 14 ; an increasing contribution, in the VZ, of newborn BPs, if these were to have a longer cell cycle than APs; or both. The second possibility is particularly relevant for consideration because, with progression of neurogenesis, an increasing proportion of APs switch to generate BPs 6 . In addition, determination of cell-cycle parameters of BPs is important per se. BPs, and SVZ progenitor cells in general, have been implicated in cortical expansion during evolution 21, 22 . In rodents, BPs have been shown to undergo symmetric proliferative divisions, which result in their expansion, and symmetric neurogenic divisions, which result in their consumption [8] [9] [10] 21, 23 . It is thus of interest to determine whether proliferative and neurogenic BPs differ in their cell-cycle parameters.
In the present study, we determined the cell-cycle parameters of BPs and compared them with APs, using cumulative labelling with thymidine analogues 24 . Compared with other approaches such as determining the time between two NPC divisions by live imaging in organotypic slice culture (for example, see ref. 20) , cumulative labelling has the advantages of being carried out in vivo and providing information on individual cell-cycle phases. However, a prerequisite for this approach is a reliable means of identifying BPs. Determining the accumulation, in the SVZ, of interphase nuclei containing an S-phase label 25 , as was previously considered appropriate for APs by analysing interphase nuclei in the VZ 12 , may not be appropriate because, in the SVZ, BPs are intermingled with postmitotic neurons that inherit S-phase label from BPs, and a substantial proportion of BP nuclei in interphase, notably those of newborn BPs in G1, are located in the VZ, intermingled with AP interphase nuclei. Consequently, we have chosen to identify BP interphase nuclei and, for comparison, AP interphase nuclei, using molecular markers rather than SVZ versus VZ location. In the embryonic mouse cerebral cortex, virtually all apical mitoses, which by definition are APs 11, 26 , are positive for Pax6, a transcription factor specifically expressed by neuroepithelial and radial glial cells and involved in their proliferation and neurogenesis [27] [28] [29] . Conversely, virtually all mitoses in the basal VZ and SVZ (collectively referred to as basal mitoses) are positive for the transcription factor Tbr2, a known marker of BPs 30, 31 that controls the production of pyramidal neurons 32, 33 . Given the availability of these molecular markers, in this study, we have developed a novel approach of determining cell-cycle parameters of APs and BPs by cumulative labelling with thymidine analogues. We find that BPs have a substantially longer G1-phase than APs, and that the previously observed G1 lengthening of neurogenic NPCs in the VZ 14 actually reflects the increasing contribution of BPs. Moreover, we used the antiproliferative gene Tis21 34, 35 , specifically Tis21-GFP knock-in mouse embryos 6 , to distinguish neuronally committed from self-expanding APs and BPs, and find that the latter exhibit a substantially longer S-phase than the former, suggesting a greater time investment into quality control of replicated DNA in expanding NPCs.
Results

Identification of APs and BPs on the basis of molecular markers.
Our study investigates NPCs in the mouse �14.5 cerebral cortex.
investigates NPCs in the mouse �14.5 cerebral cortex. NPCs in the mouse �14.5 cerebral cortex. We first confirmed the previous observations 30, 31 that Pax6 and Tbr2 23, 27, 28, 30, 31, 36 are expressed in virtually all apical and basal mitoses, respectively ( Supplementary Fig. S1 ). As described in Supplementary Note S1, we identified AP or BP nuclei irrespective of their localization in the VZ or SVZ and defined Pax6-positive/ Tbr2-negative (Pax6 + /Tbr2 − ) interphase nuclei as AP nuclei, thereby excluding interphase nuclei of newborn BPs from the AP population. Similarly, we used the neuronal marker Tbr1 (ref. 30) to define Tbr2-positive/Tbr1-negative (Tbr2 + /Tbr1 − ) interphase nuclei as BP nuclei, thereby excluding nuclei of neurons from the BP population.
To determine the extent of intermingling of AP and BP interphase nuclei in the VZ and SVZ, and the proportion of APs committed to the neurogenic lineage, we performed triple immunofluorescence for Pax6, Tbr2 and Tis21-GFP, which is specifically expressed in the sub-population of APs that generate neurons or neurogenic BPs 6, 9 ( Fig. 1a) . With regard to APs, virtually all interphase nuclei in the VZ were Pax6 + , as reported previously 27, 30, 31 . Counter immunofluorescence for Tbr2 revealed that ≈30% of Pax6 + interphase nuclei in the VZ were Tbr2 + (Fig. 1b) , indicating that APs contributed ≈70% and newborn BPs ≈30% to VZ interphase nuclei ( Supplementary  Fig. S2 ).
In the SVZ, 26% of interphase nuclei were Pax6 + , although most of these nuclei exhibited a lower level of Pax6 immunoreactivity compared with VZ nuclei. The overwhelming majority (≈85%) of Pax6 + interphase nuclei in the SVZ were also Tbr2 + and hence belonged to newborn BPs, whereas ≈15% of the Pax6 + SVZ nuclei were Tbr2 − (Fig. 1b) and presumably belonged to APs the interkinetic nuclear migration of which extended into the SVZ. Analysis of Tbr2 − /Pax6 + nuclei in the VZ and SVZ for Tis21-GFP expression showed that ≈40% of APs had switched to generating neurons or neurogenic BPs ( Fig. 1c; Supplementary Fig. S2 ).
In contrast to the partial overlap between the populations of Pax6 + and Tbr2 + nuclei, we observed very little (if any) overlap between the Pax6 + and Tbr1 + nuclei populations (Fig. 1d) . This indicated that Pax6 expression, although extending into a portion of the BP population, did not significantly extend into the population of newborn neurons. Consistent with this conclusion, we observed very little (if any) immunostaining for βIII-tubulin (Tuj1), a marker of newborn neurons, in the VZ (Fig. 1e) .
With regard to BPs, in addition to the ≈30% fraction of interphase nuclei in the VZ, the vast majority (≈90%) of interphase nuclei in the SVZ were Tbr2 + (Fig. 1f) . Counter immunofluorescence for Tbr1 revealed that < 5% of the Tbr2 + interphase nuclei in the VZ were Tbr1 + (Fig. 1g) , indicating that BPs contributed > 95% to the Tbr2 + interphase nuclei in the VZ. In the SVZ, ≈40% of Tbr2 + nuclei were also Tbr1 + and hence belonged to newborn neurons, whereas ≈60% of the Tbr2 + interphase nuclei were Tbr1 − (Fig.  1g) and hence BPs. Analysis of the Tbr1 − /Tbr2 + nuclei in the VZ and SVZ for Tis21-GFP expression showed that > 80% of BPs were neurogenic (Fig. 1h) . A summary of the population analysis in the VZ and SVZ is illustrated in Supplementary Figure S2 .
BPs have a longer cell cycle than APs. We next used the above information to determine the cell-cycle parameters of Tis21-GFPnegative (Tis21-GFP − ) and -positive (Tis21-GFP + ) APs and BPs, using cumulative labelling with 5-ethynyl-2-deoxyuridine (�dU). As described in Supplementary Note S2, it was appropriate to use �dU instead of 5-bromo-2-deoxyuridine (BrdU; Supplementary  Figs S3 and S4 ). Cumulative �dU labelling was performed in conjunction with triple immunostaining for either Pax6, Tbr2 plus Tis21-GFP (Fig. 2a,b) or Tbr2, Tbr1 plus Tis21-GFP (Fig. 2c,d ) to determine the cell-cycle parameters for APs (Tbr2 − /Pax6 + ) and BPs (Tbr1 − /Tbr2 + ), respectively, and to distinguish between proliferative (Tis21-GFP − ) and neurogenic (Tis21-GFP + ) NPC sub-populations. As shown in Figure 2e and summarized in Table 1 , this revealed that the length of G2 + M + G1 (T C -T S ), as indicated by the time point at which the �dU labelling index reached the plateau, was longer for the total population of BPs (23.3 h) than APs (14.1 h). In contrast, the proportion of the cell cycle comprising Sphase, as indicated by the intercept of the cumulative �dU labelling curve with the y axis, was smaller for BPs (12%) than for APs (26%). The growth fraction was nearly 100% for both, APs and BPs. Calculation of the length of S-phase (T S ) and the total cell cycle (T C ) 24 yielded values of 5.0 and 19.1 h for APs and 3.2 and 26.5 h for BPs. The present T C data determined by cumulative �dU labelling are very similar to those determined by live imaging in organotypic slice culture 7, 20 .
Proliferative NPCs have a longer S-phase than neurogenic NPCs.
We next analysed the cell-cycle parameters separately for Tis21-GFP − APs and BPs, that is, those destined to undergo proliferative divisions 6 , and Tis21-GFP + APs and BPs, that is, those destined to undergo BP-genic (APs) and neurogenic (APs, BPs) divisions 6,9
Pax6
Tbr2 DAPI ( Fig. 2f, Table 1 ). T C -T S was nearly identical for proliferative (14.1 h) and BP-genic/neurogenic (14.0 h) APs, and the same was the case for the longer T C -T S of proliferative (23.0 h) versus neurogenic (23.4 h) BPs. However, interestingly, the T S value of BP-genic/neurogenic APs and neurogenic BPs was significantly shorter (1.8 and 2.8 h, respectively) than that of proliferative APs and BPs (8.3 and 6.4 h, respectively). This resulted in a shorter T C of BP-genic/neurogenic APs (15.8 h) than of proliferative APs (22.4 h), and of neurogenic BPs (26.2 h) than of proliferative BPs (29.4 h). Given that the Tis21-GFP + sub-population is greater for BPs ( > 80%, Fig. 1h ) than for APs (≈40%, Fig. 1c) , the shorter S-phase duration of BP-genic/ neurogenic compared with proliferative NPCs (Fig. 2f) contributed to the observation (Fig. 2e ) that S-phase comprised a smaller proportion of the T C of BPs than of APs.
We sought to corroborate the difference between APs and BPs with regard to the S-phase proportion relative to the total cell cycle by determining the proportion of NPCs in Sphase using an independent method, that is, proliferating cell nuclear antigen (PCNA) immunostaining. Cell nuclei in S-phase typically exhibit a punctate pattern of PCNA immunoreactivity, which reflects sites of DNA replication, whereas nuclei in G1 and G2 show diffuse PCNA immunoreactivity ( Fig. 3a-d ) 37, 38 . Determination of the percentage of Pax6 + ( Fig. 3a ) and Tbr2 + ( Fig. 3b ) nuclei in S-phase by PCNA immunostaining, together with correction for the contribution of neurons to the Tbr2 + nuclei and of BPs to the Pax6 + nuclei (Fig. 1b,g ) as described in the Methods, allowed us to calculate the percentage of APs and BPs in S-phase (30 ± 4 and 14 ± 4%, respectively; Fig. 3e ). Very similar data to that shown in Figure 3e (�dU-labelled samples) were obtained when embryos not exposed to �dU were analysed (APs 26 ± 6% (n = 3); BPs 12 -14% (n = 2)). These data compare well with the mean proportion of NPCs in S-phase as determined from the intercept of the cumulative �dU-labelling curves with the y axis (Fig. 2e) .
Longer cell cycle of BPs than of APs is due to G1 lengthening. We combined �dU labelling with immunostaining for phosphohistone H3 (PH3), an indicator of late G2-and M-phase 39 , to investigate the duration of G2 and M in the various NPC populations. PH3 + cells, the mitotic state (as opposed to late G2) of which was confirmed by 4,6-diamidino-2-phenylindole (DAPI) staining, were classified as either APs or BPs on the basis of their location at the ventricular surface or in the basal VZ/SVZ, respectively (Fig. 4a,b) , and as undergoing proliferative or neurogenic division on the basis of the absence or presence, respectively, of Tis21-GFP (Fig. 4c,d) .
Analysis of the appearance of �dU label in mitotic figures (mitotic �dU labelling index) revealed a very similar time course for the four NPC populations (Fig. 4e) , with almost all mitotic NPCs becoming �dU + 2-3 h after �dU administration, indicating an average G2-length (T G2 ) of < 2 h (~1.6 h). With regard to M-phase, we first determined the percentages of total Tis21-GFP − and Tis21-GFP + APs and BPs, identified as in Figure 1 , that were in M-phase by DAPI staining and PH3 immunofluorescence as in Figure 4a -d, and then calculated the length of M-phase (T M ) in the four NPC populations from the respective T C . This revealed that T M was longer in APs than in BPs, being longest in Tis21-GFP − APs ( Table 1) .
The determination of T C , T S , T G2 and T M allowed us to calculate the length of G1 (T G1 ). T G1 was found to be almost twice as long for BPs than for APs, and for either type of NPC was not significantly different for the proliferative and BP-genic/neurogenic
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Tbr1-/Tbr2+ sub-populations (APs, 11.4 and 11.7 h, respectively; BPs, 20.9 and 21.3 h, respectively; Fig. 4f , Table 1 ).
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Higher DNA synthesis rate in Tis21-GFP + than in Tis21-GFP − NPCs. To investigate possible mechanisms underlying the S-phase shortening in Tis21-GFP + compared with Tis21-GFP − NPCs, we performed �dU pulse-labelling for 30 min in vivo and analysed dissociated single Tis21-GFP − and Tis21-GFP + NPCs, separated by fluorescence-activated cell sorting (FACS), by flow cytometry.
Comparison of the overtly �dU-incorporating Tis21-GFP − (Fig.  5a , dashed line) and Tis21-GFP + (Fig. 5b , dashed line) NPC populations revealed a 20% increase in the rate of �dU incorporation in Tis21-GFP + cells (Fig. 5c ). This increase was corroborated when only the overtly �dU-incorporating NPCs in S-phase, as defined by DNA content (Fig. 5d,e) , were quantified, and observed for cells in early and late S-phase ( Fig. 5f; Fig. 5g ,h for Tis21-GFP − ; Fig. 5i ,j for Tis21-GFP + ). Thus, Tis21-GFP + NPCs exhibited a higher rate of DNA synthesis than Tis21-GFP − NPCs, although the magnitude of this increase (1.2-fold change) was clearly less than that of the reduction in S-phase duration (3.3-fold change) in Tis21-GFP + compared with Tis21-GFP − NPCs (Fig. 4f, Table 1 , see Supplementary Fig. S2 for proportions of NPC sub-populations).
Increased PCNA level in short S-phase duration nuclei. We also analysed the intensity and sub-nuclear pattern of PCNA immunoreactivity in NPC populations with different S-phase durations. As high-resolution PCNA immunostaining was not compatible with detecting Tis21-GFP (see Methods), we combined it with Tbr2 immunofluorescence, reasoning that a Tbr2 + S-phase nucleus can be attributed to a BP and a Tbr2 − S-phase nucleus to an AP. Given that S-phase in the total BP population is substantially shorter than in the total AP population (3.2 versus 5.0 h, Table 1 ), which reflects the fact that the BP population contains twice as many Tis21-GFP + NPCs as the AP population (80 versus 40%, Fig. 1c ,h, Supplementary Fig. S2 ), comparison of PCNA immunostaining between Tbr2 + and Tbr2 − nuclei may reveal differences in the DNA replication machinery that are related to alterations in S-phase duration.
In accordance with previous observations with non-neural cells 40, 41 , we considered the following: AP and BP nuclei exhibiting diffuse PCNA immunoreactivity to be in G1 or G2 (see Fig. 3c,d) ; nuclei exhibiting numerous small PCNA puncta above the level of diffuse PCNA immunoreactivity to be in early S-phase (Fig. 6a) ; and nuclei exhibiting strong, occasionally clustered PCNA puncta well above the level of diffuse PCNA immunoreactivity to be in late S-phase (Fig. 6b) . Quantification of the average PCNA immunofluorescence of a nucleus showed that this value extended over a certain range for both early (Fig. 6c) and late (Fig. 6d) S-phase nuclei.
Plotting these values in ascending order for late S-phase nuclei revealed a significant difference between Tbr2 − and Tbr2 + nuclei (Fig. 6d) , with the mean value of Tbr2 + nuclei being 18% higher than that of Tbr2 − nuclei (Fig. 6e) , whereas no significant difference was observed between early S-phase Tbr2 − and Tbr2 + nuclei (Fig.  6c,e) . Thus, nuclei with, on average, a shorter S-phase (BPs) appear to maintain PCNA immunoreactivity at late S-phase at higher levels than nuclei with, on average, a longer S-phase (APs), although the magnitude of this increase (1.2-fold change) was less than that of the reduction in S-phase duration (1.6-fold change) in BPs relative to APs (Table 1 , see Supplementary Fig. S2 for proportions of NPC sub-populations). Moreover, the s.d. of PCNA immunofluorescence between the pixels of a given nucleus was similar for Tbr2 − and Tbr2 + nuclei in early S-phase, but was significantly higher for Tbr2 + than for Tbr2 − nuclei in late S-phase (Fig. 6f) . This suggested that the variability of clustered PCNA immunoreactivity at late S-phase was greater in nuclei with, on average, a shorter S-phase (BPs) than nuclei with, on average, a longer S-phase (APs).
Candidate genes for reducing S-phase duration of NPCs. To gain further insight into the molecules possibly involved in these cellcycle alterations, notably the S-phase shortening in Tis21-GFP + compared with Tis21-GFP − NPCs, we carried out a genome-wide analysis of changes in mRNA levels. For this purpose, living Tis21-GFP − and Tis21-GFP + NPCs in S-phase, as defined by DNA content, were isolated by FACS (Supplementary Fig. S5 ) and subjected to microarray analysis. The FACS-based separation of Tis21-GFP − and Tis21-GFP + NPCs was validated by analysis of mRNAs expected to be up-or down-regulated in these NPC populations ( Table 2, see Supplementary Note S3) .
Genome-wide analysis revealed 1,098 annotated mRNAs, the levels of which showed a statistically significant (P < 0.05) ≥1.2-fold change in Tis21-GFP + S-phase NPCs as compared with Tis21-GFP − S-phase NPCs, with 410 mRNAs being upregulated and 688 mRNAs downregulated in Tis21-GFP + cells. Table 2 lists those among the 1,098 genes the functions of which suggested that they may be involved in the observed cell-cycle phase alterations, notably the 3.3-fold reduction in S-phase duration (from 8.0 to 2.4 h, Table 1 ), in Tis21-GFP + compared with Tis21-GFP − NPCs. Indeed, alterations in mRNA levels were observed for genes involved in cell-cycle regulation and DNA replication and repair. Specifically, genes expected to be associated with a reduction in S-phase duration, such as the transcription factor E2f1 (refs 42, 43) 
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We 51) , were also upregulated. These functionally opposite changes in mRNA levels may reflect the fact that NPCs in S-phase had been isolated and subjected to microarray analysis.
The reduction in S-phase duration in Tis21-GFP + compared with Tis21-GFP − NPCs may also involve changes in gene expression that would affect the state of chromatin 52, 53 . Indeed, we observed numerous such changes in mRNA levels, including genes involved in histone modification and DNA methylation. We also identified a number of genes implicated in NPC lineage progression, the mRNA levels of which were up-or down-regulated in Tis21-GFP + compared with Tis21-GFP − NPCs ( Table  S1 , Supplementary Note S5) revealed that, remarkably, the downregulation of extracellular interactions is a major change that occurs in the transition from NPCs in S-phase destined to undergo proliferative divisions (Tis21-GFP − ) to NPCs in S-phase destined to undergo differentiative divisions (Tis21-GFP + ).
Discussion
Using cumulative �dU labelling and defining the various classes of NPCs using molecular markers rather than the location of their nuclei in histologically defined zones, our study provides the first detailed breakdown of cell-cycle parameters for the various classes of NPCs. The first key observation is that BPs have a substantially longer G1-phase than do APs. This may reflect, for example, that BPs delaminate from the apical adherens junction belt, translocate their nuclei over a greater distance in the basal direction (typically to the SVZ) than APs do in G1, and retract their apical and basal processes 5, 7, 9 . In addition, consistent with the cell-cycle length hypothesis 16, 18 , this G1 lengthening may causally contribute to the more differentiated state of BPs compared with APs, and, perhaps, promote BP fate.
Three implications of our data are addressed in the Supplementary Discussion: First, there is a need to reinterpret the previous observation 14 that Tis21-GFP + NPCs in the VZ have a longer G1 than do Tis21-GFP − NPCs; second, the present finding of an equally long G2-phase in Tis21-GFP + APs and Tis21-GFP + BPs (Fig. 4e, Table 1 ) is in contrast to a previous conclusion 14 that Tis21-GFP + BPs have a longer G2-phase than do Tis21-GFP + APs; third, the determination of T C of Tis21-GFP + BPs is valid.
The second key observation is that self-expanding NPCs have on an average a 3.3-fold (range 2.3-to 4.6-fold) longer S-phase than NPCs committed to the neurogenic lineage. In fact, the key difference in cell-cycle parameters between proliferating and neurogenic NPCs is in S-phase duration, observed with two independent experimental approaches, whereas the other cell-cycle phases remain constant for proliferating versus neurogenic APs, and for proliferating versus neurogenic BPs. This finding raises the possibility that S-phase duration is a key factor in the maintenance of proliferative capacity of NPCs. �vents in S-phase include DNA replication and repair coupled with cell-cycle checkpoints 54, 55 . It has been reported that removal of Brca1, a gene associated with DNA repair, causes massive apoptosis in early but not late NPCs 56 , suggesting a stronger requirement for the DNA repair system in proliferative compared with neurogenic NPCs. One may speculate that proliferative, more unrestricted NPCs (in terms of lineage) have a stronger requirement for DNA replication fidelity and repair, as errors would be inherited to many more progeny than errors in NPCs already restricted to differentiation 55, 57 . Our data towards mechanistic insight into the change in S-phase duration are consistent with these considerations. First, determination of the rate of �dU incorporation revealed only an ≈20% increase in Tis21-GFP + compared with Tis21-GFP − NPCs (Fig. 5) , indicating that DNA replication proceeded only a little more slowly in the latter cells and implying that their substantially longer S-phase was not due to a correspondingly lower rate of DNA synthesis. Second, in line with their 1.6-fold shorter S-phase (Table 1) , there was a 1.2-fold increase in PCNA immunoreactivity in BPs compared with APs, which was observed at late, but not early, S-phase, consistent with the activity of the DNA replication machinery remaining at a higher level in late S-phase in BPs compared with APs (Fig. 6 ).
Third, a genome-wide screen for changes in mRNA levels between Tis21-GFP − and Tis21-GFP + NPCs in S-phase revealed several genes with key roles in cell-cycle regulation, DNA replication and repair and chromatin remodelling, the alterations in expression level of which provided possible mechanistic explanations for the difference in S-phase duration and its significance (Table 2) . Thus, we observed for S-phase Tis21-GFP + compared with Tis21-GFP − NPCs an upregulation of genes implicated in increasing, and a Table 1 ). Blue bars, G1-phase; red bars, S-phase; yellow bars, G2-phase; green bars, m-phase.
downregulation of genes implicated in decreasing, S-phase duration; notably, the former included genes involved in the regulation of S-phase DNA checkpoints. Together, our data are consistent with the concept that the longer S-phase in Tis21-GFP − compared with Tis21-GFP + NPCs reflects, for the most part, an increased time investment into the quality control of replicated DNA.
It has previously been concluded 12 that S-phase duration in NPCs during cortical neurogenesis remains relatively constant. Our present finding that S-phase duration is dramatically different between proliferating and neurogenic NPCs has significant implications for studies in which conclusions about the extent of NPC proliferation are drawn from experiments using a single administration of thymidine analogues, notably BrdU. Thus, a lower proportion of BrdU-labelled cells observed after a single administration may not necessarily be indicative of a lower rate of cell proliferation, as commonly assumed, but may actually reflect a higher rate because of a reduction in S-phase duration. The present study delineates experimental approaches suitable to avoid such ambiguities.
On a more general note, our study shows that cell-cycle regulation of NPCs, a key aspect of cortical development 16, 17 , is more complex than previously assumed, involving major alterations not only in G1-phase but also in S-phase duration. The length of these cellcycle phases seems to be differentially linked to NPC proliferation versus differentiation, with G1-phase lengthening being associated with the transition to a more differentiated NPC type, and maintenance of a long S-phase with NPC expansion.
Methods
Animals. Unless indicated otherwise, all mouse embryos used were �14.5 heterozygous Tis21-GFP knock-in mice 6 (C57BL/6 background), obtained by overnight mating of homozygous Tis21-GFP males with wild-type C57BL/6 females. Noon of the day on which the vaginal plug was observed was defined as embryonic day (�) 0.5. All animal studies were conducted in accordance with German animal welfare legislation and in strict pathogen-free conditions in the animal facility of the Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. Protocols were approved by the Institutional Animal Welfare Officer (Tierschutzbeauftragter), and necessary licenses were obtained from the regional �thical Commission for Animal �xperimentation of Dresden, Germany (Tierversuchskommission, Landesdirektion Dresden).
EdU labelling. Cumulative �dU labelling was carried out by intraperitoneal injections, repeated at 3-h intervals up to 27 h, of 100 µl of 1 mg ml − 1 �dU (Invitrogen) in PBS into pregnant mice (27-32 g) carrying �14.5 embryos, corresponding to ≈3.3 mg kg − 1 of pregnant mouse. Mice were killed at the time points indicated in figures and legends, and the embryo-containing uteri were transferred to ice-cold PBS to stop further incorporation of �dU.
In the case of comparison of cumulative BrdU and cumulative �dU labelling, 100-120 µl of 10 mg ml − 1 BrdU (Sigma) in PBS, corresponding to 33-40 mg kg − 1 of pregnant mouse, was coinjected with �dU, administered as above. For FACS analysis, pregnant mice carrying �14.5 embryos were killed 30 min after a single �dU injection as above, and the embryo-containing uteri were transferred to ice-cold Tyrode's solution to stop further incorporation of �dU.
Immunofluorescence and EdU staining. Immunofluorescence and �dU staining were performed on 10-µm transverse cryosections of dorsal telencephalon prepared from paraformaldehyde-fixed heads of �14.5 embryos, subjected to cumulative �dU labelling as indicated. For details, see Supplementary Methods. Unless indicated otherwise, images are 1.2-µm optical sections.
Analysis of cell-cycle parameters.
For each of the NPC populations analysed (total APs, Tbr2 − /Pax6 + ; total BPs, Tbr1 − /Tbr2 + ; proliferative APs, Tbr2 − / Pax6 + /Tis21-GFP − ; neurogenic APs, Tbr2 − /Pax6 + /Tis21-GFP + ; proliferative BPs, Tbr1 − /Tbr2 + /Tis21-GFP − ; neurogenic BPs, Tbr1 − /Tbr2 + /Tis21-GFP + ), the proportional values of �dU-positive nuclei obtained after the various times of cumulative labelling (�dU labelling index) were used to determine the following cell-cycle parameters, using the �xcel sheet provided by Dr R. Nowakowski 24 : the growth fraction, the proportion of total cell cycle covered by S-phase, T C -T S , T C and T S . The �dU labelling index curves were plotted using the Nowakowski �xcel sheet. For estimating T G2 , we first defined NPCs as being in a mitotic state if this was revealed by both PH3 immunofluorescence and DAPI staining. Mitotic figures within three nuclear diameters from the ventricular surface were considered mitotic APs; mitotic figures in the basal half of the VZ and in the SVZ were considered mitotic BPs. The time required for half-maximal appearance of �dU label in the various mitotic AP and BP populations was taken to indicate the average T G2 . T M was calculated after determining the proportion of APs and BPs that were in mitosis, as identified by PH3 immunofluorescence and/or DAPI staining, taking into account the total cell-cycle length as determined by cumulative �dU labelling. Numbers of mitotic NPCs/total NPCs were as follows: total APs 372/7,832, Tis21-GFP − APs 234/4,677, Tis21-GFP + APs 138/3,155, total BPs 130/6,803, Tis21-GFP − BPs 19/1,037, Tis21-GFP + BPs 111/5,766; data are from 16 (mitotic APs and BPs), 17 (total APs) and 18 (total BPs) 225-µm-wide fields. The T C , T S , T G2 and T M values were then used to calculate T G1 of the respective NPC population.
Determination of the percentage of S-phase nuclei by PCNA immunostaining. The antigen retrieval protocol necessary to obtain high-resolution PCNA immunostaining such as that shown in Figure 3c ,d was not compatible with detecting Tis21-GFP by immunofluorescence, and did not yield high-quality PCNA images when combined with the present transcription factor double immunofluorescence protocol as used in Figure 1a ,f, but allowed only single transcription factor immunofluorescence. We therefore used the following approach to quantify the proportion of APs and BPs in S-phase using the pattern of PCNA immunostaining. We first determined the percentage of total Pax6 + (Fig. 3a) and total Tbr2 + (Fig.  3b ) nuclei that were in S-phase. The percentage value for the Tbr2 + S-phase nuclei obtained (11 ± 3%, n = 4, Fig. 3b ) was then corrected for the contribution of neurons (22 ± 1%, see Fig. 1g , VZ + SVZ, blue-red portion of the column), assumed to have no S-phase, to yield the percentage of BPs in S-phase (14 ± 4%, n = 4, Fig. 3e) . Next, the latter value was used to correct the percentage value obtained for Pax6 + S-phase nuclei (23 ± 2%, n = 4, Fig. 3a) for the contribution of BPs (37 ± 2%, see Quantification of PCNA immunofluorescence of S-phase cells. PCNA immunofluorescence in Tbr2 − and Tbr2 + S-phase nuclei was quantified using the previously described ImageJ macro 58 , which allows for an unbiased, fluorescence intensity-based definition of nuclear area. For each nucleus, the average PCNA immunofluorescence was the sum of the values of each pixel divided by the number of pixels of that nucleus, with subtraction of a background value (determined in the extracellular area). The macro also yielded the s.d. of the PCNA immunofluorescence signal between the pixels of a given nucleus.
Flow cytometry and FACS. Dorsal telencephalon (cerebral cortex) was dissected from �14.5 Tis21-GFP knock-in embryos in ice-cold Tyrode's solution. Dissected tissue from three embryos (one litter) was minced using a pair of small forceps and incubated for 20 min at 37 °C in 700 µl of a 1:1 mixture of DM�M and Ham's F-12 (Invitrogen) containing 0.13% (w/v) DPCC-treated trypsin (Sigma, T1005), 0.067% (w/v) hyaluronidase (Sigma, H3884) and 0.02% (w/v) kynurenic acid (Sigma, K3375), followed by addition of 0.07% (w/v) soybean trypsin inhibitor (Sigma, T6522) in 700 µl of DM�M/Ham's F-12. Tissue pieces and cells were collected by centrifugation at 600 g for 5 min and resuspended in 700 µl of DM�M/Ham's F-12 containing 0.07% (w/v) trypsin inhibitor. The cells were dissociated by gentle trituration (10-20 up-and-down passages using a P-1000 tip), collected by centrifugation at 600 g for 5 min and resuspended in 500 µl of DM�M/Ham's F-12. The cell suspension was then passed through a filter (20-µm pore size, BD Bioscience) including a 500-µl rinse with DM�M/Ham's F-12 to obtain ≈1 ml of a suspension enriched in single cells (≈6 × 10 5 ). For the determination of �dU incorporation into Tis21-GFP − and Tis21-GFP + NPCs, an aliquot of the cell suspension containing ≈10 4 cells was first analysed by flow cytometry using a FACSAria II cell sorter (BD Bioscience, run in PBS) and FACSDiva software to determine the range of Tis21-GFP fluorescence. For comparison, cells from �14.5 wild-type embryos not subjected to �dU labelling were analysed (see Supplementary Fig. S5a ). Cells with a fluorescence value > 1.05 × 10 3 U were defined as Tis21-GFP + and cells with a fluorescence value < 8 × 10 2 U (AU, arbitrary units) were defined as Tis21-GFP − (see Supplementary Fig. S5b ). Single cells (as defined by particle size, see Supplementary  Fig. S5c) were then sorted at room temperature to obtain ≈2 × 10 5 Tis21-GFP − and Tis21-GFP + cells each. Subsequent flow cytometry of an aliquot of the sorted cell suspensions revealed that Tis21-GFP − cells did not contain detectable numbers of cells with a fluorescence value > 1 × 10 3 U, and the contribution of cells with a fluorescence value > 1 × 10 3 U (AU) to the Tis21-GFP + cells was 99.5 ± 2%. Sorted Tis21-GFP − and Tis21-GFP + cells were separately processed using the Click-iT �dU Flow Cytometry Assay Kit with Alexa Fluor 647 for �dU detection, in combination with Click-iT �dU CellCycle 405-blue for DNA content determination (Invitrogen), according to the manufacturer's instructions, followed by another round of flow cytometry of the fixed and stained cells to define the populations of overtly �dU-incorporating cells and of cells in early or late S-phase, and to measure the amount of �dU incorporation into these cells. For microarray analysis, filtered cells obtained from the dorsal telencephalon of �14.5 Tis21-GFP knock-in embryos as above were incubated for 1 h at 37 °C with a vital DNA dye (2 µl of Vybrant DyeCycle Violet Stain, Invitrogen). Live cells were analysed by flow cytometry to identify the population in S-phase on the basis of the level of DNA fluorescence (see Supplementary Fig. S5d,e) , and single live cells were then sorted to collect Tis21-GFP − and Tis21-GFP + NPCs in S-phase cells, using the above FACS settings, which yielded 1-4 × 10 4 cells each per FACS run. The sorted cell suspensions were centrifuged at 600 g for 5 min, the supernatant discarded and cell pellets frozen in liquid nitrogen and stored at − 80 °C.
Microarray analysis.
Cell pellets of Tis21-GFP − and Tis21-GFP + NPCs in S-phase were thawed in 102 µl of lysis buffer supplied with a total RNA isolation kit (NucleoSpin RNA XS, Macherey-Nagel). The cell lysate from one cell pellet was used consecutively to thaw the next cell pellet until a cell lysate corresponding to 1.5-2.0 × 10 5 cells was obtained. Total RNA was extracted using the NucleoSpin RNA XS kit according to the manufacturer's instructions. RNA from three independent experiments was used to perform One-Color Microarray-Based Gene �xpression Analysis according to the manufacturer's instructions (Agilent Technologies). For each sample, 50 ng total RNA was used to prepare Cy3-labelled target cRNA with the Low Input Quick Amp Labeling Kit (Agilent Technologies). The target cRNAs were hybridized to SurePrint G3 Mouse G� 8 × 60K Microarrays (AMADID 028005, Agilent Technologies). Scanned images were analysed with Feature �xtraction software 10.7.1.1 (Agilent Technologies) using default parameters (protocol: G�1_107_Sep09, grid: 028005_D_F_20100617) to obtain background-corrected signal intensities. The data were further analysed with GeneSpring GX Software (Version 11.0, Agilent Technologies). After quantile normalization of the data and removal of unreliable signal intensities (filtering of data by expression: in three out of six experiments the signal intensity of a probe had to be above the 20th percentile to be retained in the data set), mRNAs were considered differentially expressed in Tis21-GFP + versus Tis21-GFP − cells if they had a corrected P-value < 0.05 after an unpaired t-test and multiple testing correction (Benjamini Hochberg).
GO term analysis of the differentially expressed mRNAs was performed with GeneSpring GX software, using a corrected P-value cutoff of < 0.05 to define a GO term as being significantly increased or decreased in frequency as compared with the total population of mRNAs represented on the microarray.
Statistical analyses.
P-values were determined using Student's t-test (two-sample equal variance, two tails). When indicated, the Kolmogorov-Smirnov test was used instead.
